Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    " February 10, 2010":" March 12, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet
Condition: Human Immunodeficiency Virus
Intervention:
22 Completed Kaletra in Combination With Antiretroviral Agents
Condition: Human Immunodeficiency Virus
Intervention:
23 Completed
Has Results
Kaletra: Therapy With Double Protease Inhibitors
Condition: Human Immunodeficiency Virus
Intervention:
24 Completed
Has Results
Cryptococcal Optimal ART Timing Trial
Conditions: Cryptococcal Meningitis;   HIV Infections;   AIDS
Interventions: Drug: efavirenz;   Biological: nucleoside
25 Completed
Has Results
Observational Data Analysis in EuroSIDA (MK-0518-058)
Condition: HIV-1 Infections
Intervention:
26 Completed
Has Results
Surveillance of Kaletra in Korean Patients
Condition: HIV-1 Infection
Intervention:
27 Completed
Has Results
Long-term Effectiveness and Safety in Hepatitis-co-infected Patients
Condition: Human Immunodeficiency Virus-Infection
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
28 Completed GSK1349572 Drug Interaction Study With Efavirenz
Conditions: Infections, Human Immunodeficiency Virus and Herpesviridae;   Healthy
Interventions: Drug: GSK1349572;   Drug: Efavirenz
29 Completed
Has Results
Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Condition: Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Intervention: Biological: Serostim
30 Completed Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects
Condition: HIV-1
Intervention: Biological: MYM-V101
31 Completed
Has Results
Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China
Condition: HIV-1 Infections
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
32 Completed Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status
Conditions: Fracture;   Infection, Human Immunodeficiency Virus
Interventions: Other: No Antiretroviral (ARV) Drug Exposure;   Drug: Any Antiretroviral (ARV) Drug Exposure
33 Completed Improving Sleep and Quality of Life in Adults With HIV Disease
Condition: Insomnia
Interventions: Behavioral: Music Therapy;   Behavioral: Yoga
34 Completed
Has Results
Alcohol Pharmacotherapy for HIV+ Prisoners
Conditions: Alcohol Dependence;   Problem Drinking;   Hazardous Drinking;   Human Immunodeficiency Virus;   AIDS
Interventions: Drug: Vivitrol- Intramuscular naltrexone (depot-formulation);   Drug: Placebo
35 Completed Safety of Cotrimoxazole in HIV- and HAART-exposed Infants
Conditions: Acquired Immunodeficiency Syndrome;   Infant, Newborn;   Anemia;   Neutropenia;   HIV Infections
Intervention: Drug: cotrimoxazole
36 Unknown  (Men Who Have Sex With Men) MSM Community Intervention Trial
Conditions: HIV;   Syphilis;   Herpesvirus 2, Human
Intervention: Other: behavior intervention and male circumcision
37 Completed A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos
Conditions: HIV/AIDS;   STD;   Pregnancy
Intervention: Behavioral: Computer-based parent-adolescent HIV communication
38 Completed Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting
Condition: Substance Use
Intervention:
39 Completed Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma
Condition: Kaposi's Sarcoma
Intervention: Drug: Indinavir in association with Vinblastina +/- Bleomicina

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page   
Study has passed its completion date and status has not been verified in more than two years.